UNITEDHEALTH GROUP INC
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
UNH$405.12+1.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
| For the Years Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2023 | 2022 | 2021 |
| Operating activities | |||
| Net earnings | $23,144 | $20,639 | $17,732 |
| Noncash items: | |||
| Depreciation and amortization | 3,972 | 3,400 | 3,103 |
| Deferred income taxes | (245) | (673) | 130 |
| Share-based compensation | 1,059 | 925 | 800 |
| Other, net | (505) | (331) | (944) |
| Net change in other operating items, net of effects from acquisitions and changes in AARP balances: | |||
| Accounts receivable | (3,114) | (2,523) | (1,000) |
| Other assets | (2,444) | (1,374) | (1,031) |
| Medical costs payable | 3,482 | 4,053 | 2,701 |
| Accounts payable and other liabilities | 3,516 | 1,964 | 1,162 |
| Unearned revenues | 203 | 126 | (310) |
| Cash flows from operating activities | 29,068 | 26,206 | 22,343 |
| Investing activities | |||
| Purchases of investments | (18,314) | (18,825) | (17,139) |
| Sales of investments | 7,307 | 5,907 | 7,045 |
| Maturities of investments | 9,230 | 6,081 | 8,251 |
| Cash paid for acquisitions, net of cash assumed | (10,136) | (21,458) | (4,821) |
| Purchases of property, equipment and capitalized software | (3,386) | (2,802) | (2,454) |
| Cash received from dispositions | 685 | 3,414 | 15 |
| Other, net | (960) | (793) | (1,269) |
| Cash flows used for investing activities | (15,574) | (28,476) | (10,372) |
| Financing activities | |||
| Common share repurchases | (8,000) | (7,000) | (5,000) |
| Cash dividends paid | (6,761) | (5,991) | (5,280) |
| Proceeds from common stock issuances | 1,353 | 1,253 | 1,355 |
| Repayments of long-term debt | (2,125) | (3,015) | (3,150) |
| Proceeds from (repayments of) short-term borrowings, net | 11 | 732 | (1,302) |
| Proceeds from issuance of long-term debt | 6,394 | 14,819 | 6,933 |
| Customer funds administered | (521) | 5,548 | 622 |
| Purchases of redeemable noncontrolling interests | (730) | (176) | (1,338) |
| Other, net | (1,150) | (1,944) | (295) |
| Cash flows (used for) from financing activities | (11,529) | 4,226 | (7,455) |
| Effect of exchange rate changes on cash and cash equivalents | 97 | 34 | (62) |
| Increase in cash and cash equivalents | 2,062 | 1,990 | 4,454 |
| Cash and cash equivalents, beginning of period | 23,365 | 21,375 | 16,921 |
| Cash and cash equivalents, end of period | $25,427 | $23,365 | $21,375 |
| Supplemental cash flow disclosures | |||
| Cash paid for interest | $3,035 | $1,945 | $1,653 |
| Cash paid for income taxes | 6,078 | 5,222 | 3,966 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.